Olorofim

Adult Dosing .

Dosage forms:  TAB

Investigational New Drug (IND)

[FDA approval denied, June 2023]

invasive fungal infection

[FDA approval denied]

Info: orotomide antifungal; inhibits dihydroorotate dehydrogenase, a key enzyme in pyrimidine biosynthesis

Peds Dosing .

Dosage forms:  TAB

Investigational New Drug (IND)

[FDA approval denied, June 2023]

invasive fungal infection

[FDA approval denied]

Info: orotomide antifungal; inhibits dihydroorotate dehydrogenase, a key enzyme in pyrimidine biosynthesis